Detalles de la búsqueda
1.
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
Lancet
; 397(10291): 2275-2283, 2021 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089660
2.
Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia.
Diabetes Technol Ther
; 25(4): 231-241, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36648249
3.
Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
Lancet Diabetes Endocrinol
; 11(2): 96-108, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702566
4.
The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial.
J Diabetes Sci Technol
; : 19322968221128315, 2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36172693
5.
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.
Diabetes Care
; 43(2): 389-397, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31843948
6.
No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes.
Diabetes Care
; 43(10): e118-e119, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32647055
7.
Dietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review.
PLoS One
; 9(11): e113667, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25423489
Resultados
1 -
7
de 7
1
Próxima >
>>